Overall, IL-17A is a critical mediator of chronic liver injury, mediating the interaction between liver macrophages/Kupffer cells, HSCs, and steatotic hepatocytes and initiating the transition from simple steatosis to NASH [40,41]. Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.